Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis

BACKGROUND: The prognosis of patients with combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma (CHC) is usually poor, and effective adjuvant therapy is missing making it important to investigate whether these patients may benefit from adjuvant transarterial chemoembolization (TACE)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Liu, Wei-Ren, Tian, Meng-Xin, Tao, Chen-Yang, Tang, Zheng, Zhou, Yu-Fu, Song, Shu-Shu, Jiang, Xi-Fei, Wang, Han, Zhou, Pei-Yun, Qu, Wei-Feng, Fang, Yuan, Ding, Zhen-Bin, Zhou, Jian, Fan, Jia, Shi, Ying-Hong
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350756/
https://ncbi.nlm.nih.gov/pubmed/32650743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07138-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars